Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker CBAN
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | BlackRock Portfolio Management LLC | 1.18M | 5.6% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | L. Phillip Stone, IV | 166,465 | 0.8% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone Small-Cap Financials Fund LP | 65,886 | 0.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone QP Opportunity Fund LP | 24,638 | 0.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone GP LLC | 90,524 | 0.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone Master Opportunity Fund Ltd | 75,941 | 0.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone LLC | 166,465 | 0.8% | SCHEDULE 13G/A ↗ |
| Jul 31, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Vanguard Capital Management | 1.04M | 4.9% | SCHEDULE 13G/A ↗ |
| Jul 27, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | BlackRock, Inc. | 1.41M | 6.6% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | L. Phillip Stone, IV | 2.06M | 9.8% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone Small-Cap Financials Fund LP | 65,886 | 0.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone QP Opportunity Fund LP | 432,610 | 2.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone GP LLC | 498,496 | 2.4% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone Master Opportunity Fund Ltd | 1.57M | 7.4% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone LLC | 2.06M | 9.8% | SCHEDULE 13G/A ↗ |
| Apr 29, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | Vanguard Capital Management | 1.10M | 5.2% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | L. Phillip Stone, IV | 1.71M | 8.1% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | Fourthstone Small-Cap Financials Fund LP | 65,886 | 0.3% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | Fourthstone QP Opportunity Fund LP | 342,248 | 1.6% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | Fourthstone GP LLC | 408,134 | 1.9% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | Fourthstone Master Opportunity Fund Ltd | 1.30M | 6.1% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | CBAN Colony Bankcorp, Inc. | Fourthstone LLC | 1.71M | 8.1% | SCHEDULE 13G ↗ |
| Jan 30, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | The Vanguard Group | 971,820 | 4.6% | SCHEDULE 13G/A ↗ |
| Jan 21, 2026 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | BlackRock, Inc. | 1.07M | 5.0% | SCHEDULE 13G/A ↗ |
| Oct 17, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | BlackRock, Inc. | 1.07M | 6.1% | SCHEDULE 13G/A ↗ |
| May 13, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | L. Phillip Stone, IV | 682,658 | 3.9% | SCHEDULE 13G/A ↗ |
| May 13, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone Small-Cap Financials Fund LP | 2,352 | 0.0% | SCHEDULE 13G/A ↗ |
| May 13, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone QP Opportunity Fund LP | 160,552 | 0.9% | SCHEDULE 13G/A ↗ |
| May 13, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone GP LLC | 162,904 | 0.9% | SCHEDULE 13G/A ↗ |
| May 13, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone Master Opportunity Fund Ltd | 519,754 | 3.0% | SCHEDULE 13G/A ↗ |
| May 13, 2025 | SCHEDULE 13G/A (amended) | CBAN Colony Bankcorp, Inc. | Fourthstone LLC | 682,658 | 3.9% | SCHEDULE 13G/A ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:57 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances